Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.50 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26430086 | 1.00 | PPARA (0.55) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL26430147 | 0.88 | EP300 (0.45) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL26997167 | 0.86 | PPARA (0.50) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL26430081 | 0.85 | PPARA (0.60) | PPARAPPARGEPHX2FAAHCNR1 | |
| SCHEMBL26430083 | 0.85 | PPARA (0.60) | PPARAPPARGEPHX2FAAHCNR1 | |
| SCHEMBL16984604 | 0.84 | PPARA (0.51) | PPARAPPARGEPHX2FAAHCNR1 | |
| SCHEMBL16167355 | 0.81 | ACHE (0.53) | PPARAACHE | |
| SCHEMBL17132183 | 0.81 | PPARA (0.50) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL18794618 | 0.80 | PPARA (0.59) | PPARAPPARGEPHX2FAAHCNR1 | |
| SCHEMBL1517301 | 0.78 | PPARA (0.66) | PPARAPPARGCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8378135-B2 | Multifunctional alcohols obtained from cardanol, multifunctional acrylic crosslinker and pendant phosphorous flame retardant derivatives thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2013-02-19 | — | — | US | disclosed |
| US-20090240078-A1 | MULTIFUNCTIONAL ALCOHOLS OBTAINED FROM CARDANOL, MULTIFUNCTIONAL ACRYLIC CROSSLINKER AND PENDANT PHOSPHOROUS FLAME RETARDANT DERIVATIVES THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240078-A1 | MULTIFUNCTIONAL ALCOHOLS OBTAINED FROM CARDANOL, MULTIFUNCTIONAL ACRYLIC CROSSLINKER AND PENDANT PHOSPHOROUS FLAME RETARDANT DERIVATIVES THEREOF | PFAS, PAOX, PFKFB2 | PPARA 315/4885PPARG 350/4885EP300 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.